However, 3 drug targets were shared by 2 or more disorders across disorders (i.e., DRD2 for SCZ, MDD, and SUDs; CACNA1C for SCZ, BiP; ANKK1 for SCZ and MDD; Fig. 1). The gene discussed is DRD2; the disease is major depressive disorder.